Position in RIGL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,989,798
+$461,985 QoQ
Shares Held
50,864
-10.0% QoQ
Ownership
0.272%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 156 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 0%
Shared 70%
None 30%
Common Shares in RIGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,994,233,945 across 206 Biotechnology names. RIGL ranks #120 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,247,658 | $1,613,209,155 | |
| 2 | ARGX |
Argenx SE
|
930,548 | $863,334,513 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,270,087 | $791,950,042 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,843,415 | $719,794,757 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,110,407 | $635,295,816 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
7,651,415 | $606,680,693 | |
| 7 | CYTK |
Cytokinetics Inc
|
6,931,770 | $590,517,483 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
825,714 | $443,367,129 |
All Filings in RIGL
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,989,798 | 50,864 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,527,813 | 56,502 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,441,351 | 57,001 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,749,943 | 61,770 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,195,348 | 63,820 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,104,549 | 61,398 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $588,413 | 34,983 | Shares | Defined | 2025-02-12 | |
| 2024-03-31 | $1,234,553 | 834,158 | Shares | Defined | 2024-05-15 | |
| 2022-09-30 | $1,829,240 | 1,550,204 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,876,253 | 1,660,402 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $4,964,601 | 1,660,402 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,216,658 | 1,591,192 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $5,104,506 | 1,406,200 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $30,582,112 | 7,046,570 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $21,241,864 | 6,211,072 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $39,194,997 | 11,198,571 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $32,927,980 | 13,719,993 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $28,586,776 | 15,621,191 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $24,506,141 | 15,709,067 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||